Background: Concurrent disorder or dual diagnosis refers to a combination of substance use
disorders and mental disorders that occur in the same patient simultaneously. These …

This narrative review explores the efficacy and tolerability of third-generation antipsychotics
(TGAs)—aripiprazole, cariprazine, brexpiprazole, and lurasidone—for the management of …

Background The association between cannabis use and positive symptoms in
schizophrenia spectrum disorders is well documented, especially via meta-analyses. Yet …

Background: The Duration of Untreated Psychosis (DUP) is the time between the first-
episode psychosis (FEP) and the initiation of antipsychotic treatment. It is an important …

Background: Lurasidone is an atypical antipsychotic approved for the acute and
maintenance treatment of schizophrenia. Recently, lurasidone was also extended FDA …

Background: Cannabis is the most widely used illegal drug but is rarely considered a causal
factor in death. Aims: This study aimed to understand trends in deaths in England where …

Abstract Background Natural Cannabis (NC) and Synthetic Cannabinoids (SCs) use can
increase the risk of developing psychotic disorders and exacerbate their course. Aims To …

Background: Dual disorders (DDs) involve the coexistence of a substance use disorder
(SUD) with another mental illness, often from the psychotic and affective categories. They …

Background Natural Cannabis (NC) and Synthetic Cannabinoids (SCs) use can increase
the risk and exacerbate the course of psychotic disorders. These could be influenced by the …

Introduction: Internet gaming disorder (IGD) is an emerging condition within the field of
behavioural addictions. IGD has been demonstrated to be highly comorbid with many other …